| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 3087 |
| 1 | CERTOLIZUMAB PEGOL | 1350 |
| 2 | ADALIMUMAB-AATY | 1186 |
| 3 | ERGOCALCIFEROL | 1095 |
| 4 | ADALIMUMAB | 1009 |
| 5 | INFLIXIMAB-DYYB | 1007 |
| 6 | PREDNISONE | 995 |
| 7 | INFLIXIMAB | 931 |
| 8 | TOFACITINIB | 898 |
| 9 | ACETAMINOPHEN | 850 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 1007 | 0.2922 |
| 1 | ETEPLIRSEN | 279 | 0.1156 |
| 2 | TILDRAKIZUMAB-ASMN | 215 | 0.0892 |
| 3 | VUTRISIRAN | 262 | 0.0882 |
| 4 | CASIMERSEN | 81 | 0.0822 |
| 5 | GOLODIRSEN | 38 | 0.0779 |
| 6 | GIVOSIRAN SODIUM | 119 | 0.0763 |
| 7 | USTEKINUMAB-STBA | 28 | 0.0755 |
| 8 | TROFINETIDE | 511 | 0.0696 |
| 9 | CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES | 593 | 0.0648 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 3087 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1998 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 1885 |
| 3 | Corticosteroid [EPC] | 1843 |
| 4 | Benzodiazepine [EPC] | 857 |
| 5 | Vitamin C [EPC] | 840 |
| 6 | Proton Pump Inhibitor [EPC] | 836 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 760 |
| 8 | Endothelin Receptor Antagonist [EPC] | 729 |
| 9 | Parathyroid Hormone-Related Peptide Analog [EPC] | 722 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanocortin 4 Receptor Agonist [EPC] | 15 | 0.0526 |
| 1 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 134 | 0.0348 |
| 2 | Antisense Oligonucleotide [EPC] | 399 | 0.0334 |
| 3 | Interleukin-17 Receptor A Antagonist [EPC] | 57 | 0.0277 |
| 4 | Parathyroid Hormone-Related Peptide Analog [EPC] | 722 | 0.0233 |
| 5 | Gamma Secretase Inhibitor [EPC] | 20 | 0.0217 |
| 6 | Oxaborole Antifungal [EPC] | 1 | 0.0143 |
| 7 | Bispecific HER2-directed Antibody [EPC] | 1 | 0.0122 |
| 8 | Glucosylceramide Synthase Inhibitor [EPC] | 28 | 0.0099 |
| 9 | Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC] | 1 | 0.0096 |